{
  "docId": "019de071-393b-7632-a337-54e7c94a82e1",
  "docSlug": "0665efd8ee492718ecd4a60e3f8fd33f",
  "documentTitle": "argenx SE | Results Presentation Deck | 16 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 16,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "The slide uses a Venn-like diagram to connect three core pillars to six specific business outcomes.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-393b-7632-a337-54e7c94a82e1/8",
  "deckHref": "/decks/019de071-393b-7632-a337-54e7c94a82e1",
  "deckJsonHref": "/decks/019de071-393b-7632-a337-54e7c94a82e1.json",
  "deckAnchorHref": "/decks/019de071-393b-7632-a337-54e7c94a82e1#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.35,
        "x": 0.08,
        "y": 0.135
      },
      "kind": "diagram",
      "text": "Three overlapping circles representing core pillars: Patients, Pipeline, and Science.",
      "attrs": null,
      "subkind": "venn",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10787526-0e3f-43ad-93d0-987465370022",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.5,
        "x": 0.45,
        "y": 0.15
      },
      "kind": "list",
      "text": "Global autoimmune market has surpassed $150B; Efgartigimod available globally; Vibrant neuromuscular, hematology and skin franchises; Efgartigimod in 15 indications; ARGX-117 in multiple late-stage trials; Proof-of-concept demonstrated with ARGX-119; New asset each year from IIP",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74ef44d7-3d49-4e6f-b10e-4984b8fb8fe4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.48,
        "x": 0.26,
        "y": 0.92
      },
      "kind": "paragraph",
      "text": "We believe the future belongs to those who collaborate best",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "691d3eac-4b21-4206-926c-d5c2622d28b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "argenx 2025: Building a Leading Immunology Company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1352d78a-c320-42db-9a92-cb34d098902a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "852ae9ca-281a-42a5-9f45-70ab7c58c410",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The document presents a solution on slide 5 and develops it on slides 6-8",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    },
    {
      "to": 10,
      "from": 8,
      "beatId": "20028400-8ca1-4331-ac22-0739f9f3c9ec",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The document presents market size information on slides 8-10",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "0e64f6d5-bcb4-4f93-8d22-81ecae10d41d",
      "evidence": "The document presents a 'why' on slide 3 and develops it on slides 4-10",
      "position": 0,
      "objective": "Why Efgartigimod?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 9,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "2545deac-471a-48e0-95d8-493878652df8",
      "evidence": "The document presents a cost of inaction on slides 6-9",
      "position": 1,
      "objective": "What happens if we don't act?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}